pooping a lot on tirzepatide Stop Diarrhea Tirzepatide: Practical Management Tips Does Tirzepatide Cause Bloating?

Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist activity at both the GIP and GLP-1 receptors

This dual-action mechanism not only helps control blood sugar but can also contribute to weight loss, a key factor in managing type 2 diabetes

However, it is important to note that around 44% of participants experienced nausea, and 25% reported abdominal pain, which are critical considerations when evaluating its safety profile

We encountered no countdown timers, pop-up urgency messaging, or forced upsell prompts during the intake or checkout process